Certain medications for multiple sclerosis (MS) called monoclonal antibodies, taken while breastfeeding, may not affect the development of a child during the first three years of life, according to a preliminary study released today, March 4, 2024.
CAR-T Warning for Secondary Malignancies: Warranted or Not?
Early in 2024, we reported on the FDA’s call for new boxed warnings on the labeling of all approved chimeric antigen receptor (CAR) T-cell therapies
January 6, 2025